In order to induce new bone formation, mesenchymal stem cells were seeded onto atelocollagen honeycomb scaffold. We evaluated the mechanism of bone induction by KUSA/A1 cells combined with honeycomb atelocollagen scaffold. Scaffold alone, KUSA/A1 cells alone and with scaffold were implanted in the subcutaneous pockets of 4-week-old male SCID mice. The transplants were subjected to radiographical, histological and immunohistochemical examinations after 2 and 4 weeks of implantation. Radiographically, both KUSA/A1 cells alone and KUSA/A1-Scaffold showed some radiopaque areas formation but the latter disclosed a larger amount.
INTRODUCTION
Bone regeneration is a biological process to renew damaged bone tissue. When the bony defect is small, it will usually heal by regeneration. However, if the bony defect is large, tissue grafting is needed to allow bone repair. 1 Recent progress in tissue engineering offer the prospect of sophisticated physiological in vitro models with the aim of developing materials that will help the body to heal itself. Tissue engineering is defined as an interdisciplinary field where the engineering and life sciences principles are applied toward biologic substitute generation. 2 The general strategies in bone induction by tissue engineering are: 1) infusion or implantation of tissue-inducing substances such as BMP 3 ; 2) implantation of cells on or within matrices. 4 In bone engineering, rhBMP combined with collagen is an effective material as biological onlay implant, showing osteoinductive properties and being completely replaced by new bone. 5 Mature KUSA/A1 osteoblasts, in combination with PLGA-collagen sponge, show promise for use in custom-shaped bone regeneration tool for basic research into osteogenesis and for development of therapeutic applications. 6 Until now, the best structure of the scaffold for stem cells and the precise shape and size of the new tissue have not been determined in bone engineering. However, we recently reported that honeycomb-like structure is a good candidate as scaffold for KUSA/A1 cells to induce the precise amount of new bone within a confined area . 7 Thus, to clarify the mechanism of bone induction by KUSA/A1 cell using atelocollagen honeycomb scaffold, we evaluated the mechanism of bone induction by KUSA/A1 cells combined with porous atelocollagen and the advantage of stem cells in bone engineering implanted in SCID mice subcutaneous tissues.
MATERIALS AND METHODS

Cell culture
In this study, KUSA/A1 cells (kindly provided by Dr. Umezawa from Keio University, Tokyo, Japan) were used. 8 These fibrocytic cells are marrow stromal cells obtained from primary bone culture of female C3H/He mouse. The cells were cultured in minimum essential medium alpha medium (α-MEM, GIBCO BRL, Inc., USA) supplemented with 10% fetal bovine serum (SIGMA, USA) and X1 antibiotic-antimycotic (GIBCO, USA). Then, they were seeded in 10 cm cell culture dishes (Falcon, Inc., USA) and incubated at 37ºC in humid air with 5% CO 2 . The growth medium was changed every 3 days until the cells were nearly confluent.
Atelocollagen honeycomb scaffold
The atelocollagen honeycomb scaffold (KOKEN, Japan) 3x3x2 mm 3 in size, composed by multiple collagen membranes (1m in thickness) with honeycomb-shape were used. The scaffold presents parallel pores extended from surface to surface. 9
Three-dimensional culture
When the cells became nearly confluent, they were harvested with trypsin-EDTA and placed at a concentration of 2x10 5 cell/ml onto atelocollagen honeycomb scaffold in suspension culture treated dishes. The cells were grown for 10 days at 37ºC in humid air with 5% CO 2. The medium was changed every 3 days.
Animals
In this study, we used twelve 4-week-old male Severe Combined Immunodeficient 
Subcutaneous implantation and explantation
SCID mice were subjected to intramuscular anesthesia with Ketamine (Fuji Chemical Industry Co., Ltd. Japan) and Dormitol (Meiji Seika Kaisha LTD. Japan).
Honeycomb scaffold alone, KUSA/A1 cells alone and with scaffold were implanted in the subcutaneous pockets of four SCID mice in each group. On the left side of the back, ten atelocollagen honeycomb scaffold combined with 1x10 6 KUSA/A1 cells were implanted in the subcutaneous pockets and sutured. On the right side of the back, 5x10 6 of KUSA/A1 cells alone and Scaffold alone, as control, were implanted in subcutaneous tissues. The animals were sacrificed with an overdose of ether at 2 and 4 weeks after implantation. All specimens and surrounding tissues were removed and fixed by 4% paraformaldehyde and subjected to soft X-ray (SOFTEX). Then, they were decalcified with 10% EDTA, embedded in paraffin, sectioned at 4 µm in thickness, and stained by hematoxylin-eosin (H&E). Moreover, the implants were subjected to immunohistochemical studies ( Fig.1 ).
Immunohistochemical staining of CD-34, PCNA, and Osteopontin (OP)
The sections were immunostained with monoclonal antibodies against CD-34 (abcam，UK) using Vectastain ABC (Adivin-Biotin-peroxidase Complex, USA) Rat Kit method, Osteopontin (IBL, Japan) and PCNA (Novocastra, UK) using Vectastain ABC Mouse Kit method (USA). The main steps were as follows: 1) incubation by primary antibody at 4ºC overnight. The primary antibody optimal dilutions were performed as follows: (CD-34) 1:100, (OP) 1:50 and (PCNA) 1:100; 2) incubation by anti-rat IgG 
Immunohistochemical staining of type I collagen (Col I) and Osteocalcin (OC)
The sections were also immunostained with polyclonal antibodies against Collagen type I (LSL, Japan) and Osteocalcin (LSL, Japan) using PAP method (DAKO, Denmark). The main steps were as follows: 1) incubation with primary antibody Col I 
RESULTS
Radiologic examination
At 2 weeks, in Scaffold alone, the scaffold did not show any radiopacity ( Fig.2A ).
KUSA/A1 alone implants revealed weak and small radiopacity with indistinct border (Fig.2C ). In KUSA/A1-Scaffold, the scaffolds were partially filled with a weak, wide and diffuse radiopacity ( Fig.2E ).
At 4 weeks, in Scaffold alone, the scaffold did not show any radiopacity (Fig.2B ).
KUSA/A1 alone at 4 weeks showed irregular and small islands of radiopacities. The radiopacities were homogeneous and dense with well defined border ( Fig.2D ). In KUSA/A1-Scaffold, the scaffolds were filled with radiopaque areas of different degrees of calcification and diffuse border ( Fig.2F ). KUSA/A1-Scaffold showed larger but less dense radiopacity than KUSA/A1alone at 2 and 4 weeks.
Histologic Examination
Scaffold alone at 2 and 4 weeks
They presented fibrous connective tissue with scanty inflammatory infiltration in the periphery of the scaffold. New bone formed neither was not detected (Fig.3A,B ).
KUSA/A1 alone at 2 weeks
They showed few small islands of new bone formation surrounded by areas of cellular proliferation and areas having a thin layer of KUSA/A1 cell. The newly hard tissue consisted of immature bone with evidence of osteocytes within their lacunae and vessel formation ( Fig.3C ).
KUSA/A1-Scaffold at 2 weeks
The specimens showed areas with cellular proliferation and vessel formation, and areas of immature bone not attached the collagen within the porous of the scaffold.
Some spaces of collagen membrane of the scaffold revealed many vessels formation with few cells. Moreover, the whole scaffolds were surrounded by proliferating KUSA/A1 cells (Fig.3E ).
KUSA/A1 alone at 4 weeks
The specimens showed islands of immature bone surrounded by a thin layer of cells. The new bone formed was composed of lamellae irregular rings. Moreover, these bones are more mature compared to the bone formed in KUSA/A1-Scaffold ( Fig.3D ).
KUSA/A1-Scaffold at 4 weeks
The specimens showed that the scaffolds were completely filled with new bone, excessive cellular proliferation and vessel formation. The new hard tissue was formed at the periphery of the scaffold and the center was filled with high cellularity.
The new hard tissue was formed of irregular trabeculae surrounded in the periphery by a thin layer of KUSA/A1 cells (Fig.3F) . 
DISCUSSION
The basic principle of tissue engineering is to use seeded cells and biocompatible and biodegradable scaffold to generate a certain type of tissue either in vitro or in vivo.
Most studies of bone tissue engineering focus on searching ideal osteogenic seeded cells and optimal scaffolds bone engineering.
Intramembranous ossification is characterized by capillary ingrowths into a mesenchymal region of embryonic connective tissue, followed by mesenchymal cell differentiation into osteogenic cells that secrete collagen and mineral to produce woven bone. This woven bone is later remodeled into mature lamellar bone. In this study, the process of bone formation within a pore of the scaffold demonstrated that, first, there was excessive vessel formation strongly positive for CD 34 and few cells ( Fig.4A. Stage I)). After vessel invasion within the pore of the scaffold, there was high cellular proliferation, strongly positive for PCNA ( Fig.4A . Stage II)), was followed by cellular differentiation with osteoid matrix formation, which were positive for Col I (Fig.4B. Stage III). The bone matrix starts in the center of the micromass and also from the collagen membrane. Finally, there was bone formation positive for OC ( Fig.4B. Stage   IV) ). This result shows that the mechanism of bone induction is similar to intramembranous bone formation.
It is well known that vascularization is an important prerequisite for osteogenesis. 10, 11 Atelocollagen honeycomb scaffold contains parallel tubes easily invaded by vessels in vivo. The number of the vessels, which were strongly positive to CD34, increased in KUSA/A1-Scaffold at 2 and 4 weeks. On the other hand, KUSA/A1 cells alone consisted of few vessel formations. These results suggest that this scaffold is an efficient conductor for vessel invasion and enhances the vessel formation. The angiogenesis might be stimulated by hypoxic microenvironment in a large scaffold. A shortage of oxygen causes an increase in KUSA/A1 cells of angiogenic growth factors, which diffuses through the host tissue, and acts on nearby endothelial cells. 12, 13 As it has been previously reported, proliferating cell nuclear antigen (PCNA) is immunopositive in cellular proliferation of osteo/chondrogenic cells during the process of bone formation. 14 KUSA/A1-Scaffold at 2 weeks showed excessive cellular proliferation being strongly positive for PCNA marker (Fig.4A. Stage II) . In contrast, KUSA-A1 cells alone revealed only few nuclei stained with PCNA. These results showed that this scaffold enhanced cellular proliferation being easily invaded with vessels in the whole carrier offering oxygen supply for the cells, which permitted KUSA/A1 cells to proliferate within porous of the scaffold during the first 2 weeks.
Interestingly in this study, although the cells were cultured without osteogenic medium and implanted as pre-confluent KUSA/A1 cells, they differentiated into osteoblast-like cells after implantation in vivo. At 4 weeks, the scaffold was filled with new bone formation and many proliferating cells. As it has been reported, the micromass culture indicated that cell-cell contacts were important for the differentiation process. 15, 16 The micromass inoculation corresponds to the state of condensation of mesenchymal cells during membranous bone formation, which amplifies the number of pre-osteoblasts. 17 We believe that these cells are capable to form micromass-like structure within porous of the scaffold that would permit cell-cell contact inducing osteoblast differentiation expressed by Col I and OC markers ( Fig.4B . Stage III).
In summary, the process of bone formation by KUSA/A1 cells within a pore of the scaffold is: 1) presence of few KUSA/A1 cells within the scaffold; 2) stimulation of angiogenesis; 3) cellular proliferation forming micromass followed by osteoblast differentiation with initial matrix formation; 4) induction of bone matrix from the center of the micromass, and also from the collagen membrane; 5) bone formation attaching the collagen membrane of the scaffold at 4 weeks. (Fig.5 ).
In conclusion, less amount of stem cells are capable to induce the precise amount of new bone within a confined area compared to KUSA/A1 cells alone. The new bone within a pore of the scaffold starts from the center of the micromass and also from the collagen membrane of the scaffold. This study support that atelocollagen honeycomb scaffold plays an important role in cellular anchorage and in vessel invasion, giving the precise shape and size for the new bone formation. Fig.1 . Scheme of Experimental Design.
Figures legends
Atelocollagen honeycomb scaffolds combined with KUSA/A1 cells were implanted on the left side of subcutaneous pockets.
Scaffold alone and KUSA/A1 alone were implanted on the right side of subcutaneous tissues. The animals were sacrificed at 2 and 4 weeks after implantation and subjected to radiografical examination, histological examination and immunohistochemical examination. 
